Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and vitamin K for bleeding prevention in TURP surgery
IRCT20181031041515N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of tranexamic acid and phytomenadione in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Islamic Azad University. Primary endpoints: Incidence of hematuria, Reduction in hemoglobin levels and 1 more. Started Nov 2018; status: completed.
02
Drugs
tranexamic acidphytomenadione
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20181031041515N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181031041515N1.